Microbiology News and Research

RSS

Advanced Instruments receives FDA approval to market GloCyte System

Advanced Instruments, Inc., a leader in laboratory instrumentation, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its GloCyte Automated Cell Counter System and GloCyte Low and High Level Controls.

22 Jul 2016

New study identifies alternative route for tuberculosis infection

Researchers from UT Southwestern Medical Center have identified a new way that tuberculosis bacteria get into the body, revealing a potential therapeutic angle to explore.

22 Jul 2016

Key gene controls ability of adult stem cells to regenerate muscle after injury, study finds

A key gene enables the repair of injured muscle throughout life. This is the finding of a study in mice led by researchers at NYU Langone Medical Center and the University of Colorado at Boulder, and published online July 21 in Cell Reports.

21 Jul 2016

Researchers find dangerous antibiotic-resistant bacteria in wastewater from broken sewer lines

University of South Florida researchers investigating the aftermath of a September, 2014 sewer line break in St. Petersburg, Florida, have found dangerous antibiotic-resistant bacteria in the untreated wastewater that gushed into neighborhoods and into Boca Ciega Bay at a rate of 250 to 500 gallons per minute.

20 Jul 2016

Scientists find new way to clear urinary tract infections

The process cells use to secrete chemicals also appears to be the way to clear urinary tract infections, or UTIs, according to a study by researchers from Duke Health and Duke-National University of Singapore Medical School.

20 Jul 2016

Scientists detect gut bacteria in deepest reaches of failing lungs

No one knows for sure how they got there. But the discovery that bacteria that normally live in the gut can be detected in the lungs of critically ill people and animals could mean a lot for intensive care patients.

19 Jul 2016

First clinical study for Zika vaccine to begin in Canada

Université Laval's Infectious Disease Research Centre and Centre de recherche du CHU de Québec-Université Laval are proud to announce that the first clinical study for a Zika vaccine in Canada is set to begin in Quebec City.

19 Jul 2016

Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

A biopharmaceutical company collaborating with Hawai'i scientists on an Ebola vaccine announced encouraging news about its vaccine today.

19 Jul 2016

Intranasal vaccine may provide long-term protection against multiple flu strains

Intranasal flu vaccines may be able to provide long-lasting protection against pandemic flu strains, according to a new study from immunologists at Columbia University Medical Center.

19 Jul 2016

Immune system signaling can directly affect social behavior

Using a systems-biology approach, scientists at the University of Massachusetts Medical School made a startling discovery that immune system signaling can directly affect, and even change, social behavior in mice and other model animals.

18 Jul 2016

Rare antibiotic compound detected in fungi for first time

Besides mushrooms such as truffles or morels, also many yeast and mould fungi, as well as other filamentous fungi belong to the Ascomycota phylum. They produce metabolic products which can act as natural antibiotics to combat bacteria and other pathogens. Penicillin, one of the oldest antibiotic agents, is probably the best known example.

18 Jul 2016

Scientists discover key 'twist' in Rubik's cube-like plant puzzle

Scientists at the John Innes Centre have discovered a key "twist" in a Rubik's cube-like plant puzzle, which could pave the way to new, or more effective pharmaceuticals.

18 Jul 2016

Novel method can test multi-drug resistant bacteria’s susceptibility to antibiotics in clinical setting

The recent emergence of bacterial infections that are resistant to many existing antibiotics is driving an urgent need for tools to quickly identify the small number of therapies that are still effective for individual patients.

15 Jul 2016

Antibodies from survivors of filovirus infection may offer protection against other filoviral diseases

Ebola and Marburg filovirus disease outbreaks have typically occurred as isolated events, confined to central Africa.

13 Jul 2016

Fecal transplants may help treat home and hospital-acquired scourge

Fecal transplants are increasingly being used as the treatment of last resort for certain infections in the human gut and have had remarkable success treating the nursing home and hospital-acquired scourge, Clostridium difficile colitis, an infectious diarrhea that often follows antibiotic treatment.

13 Jul 2016

Italian researchers identify new variant of emerging antibiotic resistance mechanism

A team of Italian investigators has discovered a new variant of an emerging antibiotic resistance mechanism. The new variant, dubbed mcr-1.2, confers resistance to colistin, a last-resort antibiotic against multidrug-resistant Gram-negative pathogens.

13 Jul 2016

Researchers identify new mechanism by which bacteria outsmarts immune system

Bacteria are rapidly developing resistance mechanisms to combat even the most effective antibiotics.

13 Jul 2016

Scientists discover new mechanism by which TNF protects against intracellular pathogens

Tumour necrosis factor (TNF), a messenger substance in the immune system, plays an important role in triggering chronic inflammatory diseases. For this reason, TNF inhibitors are a standard form of treatment for patients with rheumatoid arthritis and certain inflammatory bowel diseases.

11 Jul 2016

UTSA researcher elucidates innovative strategies to track disease-causing pathogens

In a new study published in Frontiers in Microbiology, Mark Eppinger, assistant professor in the Department of Biology at The University of Texas at San Antonio describes innovative strategies to track disease-causing pathogens like E. coli. Eppinger hopes his research will aid in halting and preventing large-scale outbreaks.

11 Jul 2016

Microbes detected in Boston subway system have low pathogenic potential, study shows

Boston's subway system, known as the T, might be just as bacteria-laden as you'd expect but organisms found there are largely from normal human skin and incapable of causing disease, according to a study published June 28 in mSystems, an open access journal of the American Society for Microbiology.

8 Jul 2016

Microbiology News and Research

Advanced Instruments receives FDA approval to market GloCyte System

New study identifies alternative route for tuberculosis infection

Key gene controls ability of adult stem cells to regenerate muscle after injury, study finds

Researchers find dangerous antibiotic-resistant bacteria in wastewater from broken sewer lines

Scientists find new way to clear urinary tract infections

Scientists detect gut bacteria in deepest reaches of failing lungs

First clinical study for Zika vaccine to begin in Canada

Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

Intranasal vaccine may provide long-term protection against multiple flu strains

Immune system signaling can directly affect social behavior

Rare antibiotic compound detected in fungi for first time

Scientists discover key 'twist' in Rubik's cube-like plant puzzle

Novel method can test multi-drug resistant bacteria’s susceptibility to antibiotics in clinical setting

Antibodies from survivors of filovirus infection may offer protection against other filoviral diseases

Fecal transplants may help treat home and hospital-acquired scourge

Italian researchers identify new variant of emerging antibiotic resistance mechanism

Researchers identify new mechanism by which bacteria outsmarts immune system

Scientists discover new mechanism by which TNF protects against intracellular pathogens

UTSA researcher elucidates innovative strategies to track disease-causing pathogens

Microbes detected in Boston subway system have low pathogenic potential, study shows

eBook: How to Implement Colony Picking Workflows eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo